151. Diallyl sulfide alleviates cyclophosphamide-induced nephropathic encephalopathy in rats
- Author
-
Shereen M. Galal, Abeer A. Elkhoely, and Heba H. Mansour
- Subjects
Male ,Cyclophosphamide ,Health, Toxicology and Mutagenesis ,Encephalopathy ,010501 environmental sciences ,Pharmacology ,Sulfides ,Toxicology ,Kidney ,01 natural sciences ,Receptors, N-Methyl-D-Aspartate ,Nitric oxide ,03 medical and health sciences ,chemistry.chemical_compound ,Glial Fibrillary Acidic Protein ,medicine ,Animals ,0105 earth and related environmental sciences ,0303 health sciences ,Brain Diseases ,Glial fibrillary acidic protein ,biology ,030302 biochemistry & molecular biology ,Brain ,medicine.disease ,Rats ,Allyl Compounds ,Oxidative Stress ,C-Reactive Protein ,Diallyl sulfide ,chemistry ,biology.protein ,Cytokines ,Kidney Diseases ,Organosulfur compounds ,medicine.drug - Abstract
Diallyl sulfide (DAS) is a garlic-derived organosulfur compound. The current study was planned to evaluate the protecting effects of DAS against cyclophosphamide (CP)-induced nephropathic encephalopathy. DAS (100 mg/kg) was orally administered for 4 days, 60 min after the last dose, rats were injected with CP (150 mg/kg). DAS treatment before CP significantly decreased serum urea, creatinine, sodium, potassium, calcium, blood urea nitrogen (BUN), C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-1β (IL-1ß) and tumor necrosis factor-alpha (TNF-α) compared with CP-treated rats. DAS treatment decreased malondialdehyde (MDA) and increased superoxide dismutase (SOD) and reduced glutathione (GSH) levels in the renal tissues and significantly attenuated the elevated neurotransmitters N-methyl-D-aspartate/adenosine triphosphate (NMDA), γ-aminobutyric acid (GABA) levels and remarkably restored neuronal nitric oxide (NO) level and nitric oxide synthase (nNOS) activity in the brain compared to CP-treated rats. DAS for 4 consecutive days before CP showed moderate positive immunohistochemically expression of the glial fibrillary acidic protein (GFAP) in the brain and kidney tissues comparable to CP-treated rats. DAS afforded renal and neuroprotection against CP-induced nephropathic encephalopathy due to its capacity to ameliorates the afore-mentioned biochemical parameters which were supported by histopathological and immunohistochemically examination.
- Published
- 2019